# Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC

> **NCT02734069** · — · RECRUITING · sponsor: **Instituto Nacional de Cancerologia de Mexico** · enrollment: 132 (estimated)

## Conditions studied

- Lung Cancer
- Sarcopenia
- Toxicity

## Interventions

- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT02734069
- **Lead sponsor:** Instituto Nacional de Cancerologia de Mexico
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2016-02
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2025-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02734069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02734069, "Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02734069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*